Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic. Clin Adv Hematol Oncol. 2020 07; 18(7):400-403.
View in:
PubMed
subject areas
Betacoronavirus
CD4-Positive T-Lymphocytes
Coronavirus Infections
Cytotoxicity, Immunologic
Gene Expression
Hematologic Neoplasms
Humans
Immunotherapy, Adoptive
Lymphocyte Activation
Pandemics
Pneumonia, Viral
Receptors, Antigen, T-Cell
Severity of Illness Index
T-Lymphocytes, Cytotoxic
authors with profiles
Michael Bishop